Oncogenetics

Dr.Banu Arun is Professor in Department of Breast Medical Oncology, Co-Medical Director of the Clinical Cancer Genetics Program and Section Chief Breast Genetics, Prevention and Screening at the University of Texas MD Anderson Cancer Center. Her research focuses on identifying risk biomarkers for breast cancer and prevention, and characterizing risk factors in a cohort of high-risk women with hereditary gene mutations (BRCA and others) as well as assessing breast cancer biology in these patients. She has served as the Principal Investigator on several clinical trials evaluating agents such as letrozole, imatinib, gemcitabine, R115777 and PARP inhibitors for metastatic breast cancer (including BRCA positive,) and celecoxib, atorvastatin and dasatinib in short-term breast cancer prevention trials. Given her national and international expertise she has served in several committees, including ASCO Prevention and currently serves as the Co-Chair for the SWOG Prevention and Epidemiology Committee and member of the NCCN Breast Cancer Risk Reduction Guideline Committee, member of the ASCO BOLD task force, member of ASCO IDEA committee, and member of the NCI Cancer Prevention Steering Committee. She served as grant reviewer for Susan Komen and NCI P01 and reviewed for journal including JCO, Cancer, BMJ, Cancer Prevention and Epidemiology, amongst others. She has more than 200 peer reviewed publications.

Pathology - Head and Neck Program

Pediatric Tumors Program

Basic and Translational Science

Dr. Dominissini holds a B.S. in Medical Sciences from the University of Tel-Aviv, Israel, in 2007. During his Ph.D. program, he studied RNA post-transcription modifications focusing on adenosine deamination and methylation. He carried out his post-doctoral studies at professor Chuan’s laboratory at the University of Chicago, USA, where he developed new chemical approaches for studying RNA post-transcriptional modifications. His most important papers have been cited more than 700 times. Dan described the map to locate adenosine methylation in all human RNAs. Dan was the recipient of the Science & Scilife Lab Prize for Young Scientists in 2014. Today his laboratory focuses on studying RNA epigenetic modifications at Sheba Cancer Research Center, Tel-Aviv University.

Basic and Translational Science

Dr. Daniel DeCarvalho Canada Research Chair in Cancer Epigenetics and Epigenetic Therapy Helen M Cooke Associate Professor in Cancer Epigenetics, Department of Medical Biophysics, University of Toronto Senior Scientist, Princess Margaret Cancer Centre, University Health Network
Dr. De Carvalho is the Helen M Cooke Associate Professor in Cancer Epigenetics at the Dept. of Medical Biophysics, University of Toronto and a Senior Scientist and Canada Research chair at the Princess Margaret Cancer Centre. Dr. De Carvalho earned his PhD in Immunology from University of São Paulo in 2009 and did his postdoctoral training in Cancer epigenetics at University of Southern California (USC) until 2012. His research focuses on understanding the molecular mechanisms driving epigenetic reprogramming in cancer and on translational aspects of cancer epigenetic therapy. Dr. De Carvalho is interested in the potential to use epigenetic therapy to improve immunotherapy in cancer and in using DNA methylation profiling of cell free DNA as a biomarker for cancer early detection and for response to therapy. His works have been featured by NEJM, Cell, Nature Medicine, JCO, and the Wall Street journal. Nature Medicine highlighted his most recent paper as one of the top 10 notable advances in 2015 and Canadian Cancer Society as one of the Top 10 Research Impact Stories of 2015. Dr. De Carvalho have received multiple awards for his research on cancer epigenetics, including the Canadian Cancer Society Bernard and Francine Dorval Prize, CIHR new investigator salary award and CIHR Institute of Cancer Research Early Career Award in Cancer.

Pathology - Head and Neck Program

Diana Bell is an Associate Professor in the Head and Neck section of Department of Pathology, with joint appointment in the Head and Neck Surgery, University of Texas MD Anderson Cancer Center. She is a member of several professional organizations, including North American Head and Neck Society, European Society for Pathology and Head and Neck Working Group, American Head and Neck Society, North American Skull Base Society, American Association for Cancer Research. A dedicated head and neck pathologist, Bell’s research interest focuses on sinonasal and salivary gland tumors. The aim of her research is to find and apply new strategies and technologies to better understand key molecular changes during the pathogenesis of head and neck cancers, with emphasis on salivary gland and sinonasal tumors. Dr. Bell is a member of the WHO 2016 Consensus and Editorial Study Section of Head and Neck Tumors.

Innovations and Technology

Dr. Rhee serves as Chief Health Officer of IBM, where he has global responsibilities for Watson Health and assuring a Culture of Health at IBM. Prior to joining IBM, Dr. Rhee was Chief Public Health Officer at the Health Resources and Services Administration (HRSA), which is the primary federal agency for improving access to health care services for people who are uninsured, isolated, or medically vulnerable. Dr. Rhee also served as Director of the Office of Innovation and Program Coordination at the National Institutes of Health (NIH), which is the primary federal agency for research. Prior to his federal government service, he worked in community health settings as the Chief Medical Officer of Baltimore Medical System Inc., the largest network of Federally Qualified Health Centers in Maryland. In addition, Dr. Rhee served five years as a National Health Service Corps Scholar and Medical Director at Upper Cardozo Health Center, the largest community health center in Washington, DC.

Dr. Rhee was a Chief Resident and performed his medical residency training in both internal medicine and pediatrics at Cedars-Sinai Medical Center in Los Angeles. He obtained his medical degree from the University of Southern California. Dr. Rhee also holds a master's degree in public policy from the John F. Kennedy School of Government, Harvard University with a concentration in Health Care Policy. He acquired his Bachelor in Science degree from Yale University in Molecular Biophysics and Biochemistry.

Communication and Stress Management

Gary Rodin is the University of Toronto/University Health Network Chair in Psychosocial Oncology and Palliative Care and Head of the Department of Supportive Care at Princess Margaret Cancer Centre in Toronto, Canada. Dr. Rodin is also the Director of the Global Institute of Psychosocial, Palliative and End-of-Life Care (GIPPEC) and a Professor of Psychiatry at the University of Toronto. He leads a clinical and research program on the psychosocial dimensions of advanced and terminal disease and on the development and evaluation of novel interventions to improve the quality of life and the quality of dying and death in this population. These integrated psychosocial and palliative interventions include Managing Cancer and Living Meaningfully (CALM), a supportive-expressive psychotherapeutic treatment for patients with metastatic cancer and their caregivers, and an integrated emotion and symptom-focused intervention for individuals diagnosed with life-threatening hematological malignancies of acute onset. Through GIPPEC, a University of Toronto Interdisciplinary Institute based at Princess Margaret, Dr. Rodin has established international partnerships in Europe, Asia, Africa, Australia and the Middle East to contribute to global access to palliative and supportive care for patients and families facing advanced disease and the end of life. He has published widely in these areas and is recognized internationally for his efforts to improve the rigor of research and the effectiveness and availability of psychosocial and palliative interventions.

Basic and Translational Research Program

Giorgio Trinchieri, M.D., has been the Director of the Cancer and Inflammation Program, CCR, NCI since 2006. He received his M.D. from the University of Torino. After serving as Assistant Professor of Medical Genetics at that University, as well as a member of the Basel Institute for Immunology, Dr. Trinchieri moved to Philadelphia were he raised to the rank of Hilary Koprowski endowed Professor and Chair of the Wistar Institute's Immunology Program as well as Wistar Professor of Medicine at the University of Pennsylvania Medical School. He then served as Director of the Schering-Plough Laboratory for Immunological Research in Dardilly, France, and as an NIH Fogarty Scholar in the Laboratory for Parasitic Diseases at the National Institute of Allergy and Infectious Diseases. Dr. Trinchieri is an international authority on the roles of cells and cytokines in the innate immune response to infections and cancer. He discovered Interleukin-12 (IL-12), a cytokine that plays a pivotal role in the induction of innate and adaptive cellular immunity. His laboratory’s main focus is the role of inflammation, innate resistance, immunity, and commensal microbiota in carcinogenesis, cancer progression, and prevention or destruction of cancer. His many awards and honors include the W. B. Coley Award for Distinguished Research in Basic and Clinical Immunology, the Richard V. Smalley, M.D., Memorial Award, the Milstein Award from the International Society for Interferon and Cytokine Research, the Honorary Membership in the Italian Society of Immunology and Allergy, and the Lifetime Honorary Membership Award from the International Cytokine Society.

Basic and Translational Research Program

Dr. Glauco R. Souza is the President, CSO, and co-founder of Nano3D Biosciences, Inc. (n3D). He is one of the co-inventors and inventor of all patents related to n3D’s 3D cell culturing by magnetic levitation and magnetic 3D bioprinting technologies. Dr. Souza is also Adjunct Assistant Professor at University of Texas Health Science Center at Houston. Prior to co-founding n3D, Dr. Souza was an Odyssey Scholar at UT MD Anderson Cancer Center. During his work at MD Anderson, he applied a multidisciplinary approach to developing nanotechnology tools for tissue targeted imaging, gene delivery, and tissue engineering. Towards the end of his Odyssey Scholarship tenure at MD Anderson, in collaboration with Rice University, the genesis of 3D cell culturing by magnetic levitation and magnetic 3D bioprinting took place. Results using these groundbreaking technologies have been reported in various high-impact scientific journals, including Nature Nanotechnology, Proceedings of the National Academy of Sciences, Nature Protocols, and Nature Reviews Cancer. Now, Glauco’s research mission is to advance magnetic 3D cell culturing into a routine laboratory tool that will measurably improve the drug discovery process, cancer research, and regenerative medicine. Recently, Glauco was an invited speaker at TEDx Houston, where he shared his thoughts and experience on resonating aspects between science, levitating cells, friendship, and sports as key ingredients for scientific discovery and the entrepreneurial process. Dr. Souza’s research has been funded by grants from National Science Foundation (NSF), National Institute of Health (NIH), Department of Defense (DOD), Center for Advancement of Science in Space (CASIS), and Texas Emerging Technology Fund (ETF). Dr. Souza received B.S. in Chemistry and M.S. and Ph.D. in Physical Chemistry from The George Washington University in Washington DC (GWU).

Hematology-Oncology

Dr. Avanzi is a graduate of Medicine from the School of Medicine at Pontifícia Universidade Católica de Campinas. He finished his residency program in Internal Medicine and Hematology from Universidade de São Paulo – Ribeirão Preto. Ph.D. degree from the New York Blood Center/Santa Casa de São Paulo with research on stem-cell and cell therapy. Postdoctoral program from Memorial Sloan Kettering Cancer Center, where his research focused on CAR T-cell immunotherapy. Currently Dr. Avanzi is the Medical Director at Kite Pharma and he works with CAR T-cells for treating hematology-oncology diseases.

Head and Neck Program

Nishant Agrawal, MD, specializes in the management of patients with benign and malignant tumors of the head and neck. Dr. Agrawal's work has achieved international recognition in the field of head and neck surgical oncology, and head and neck cancer genetics. Under his leadership, a team of researchers completed a landmark study that examined the genome of head and neck squamous cell carcinoma. His group then followed up by publishing the genomic landscapes of the remaining major head and neck cancers, including esophageal squamous cell carcinoma, esophageal adenocarcinoma, medullary thyroid cancer, adenoid cystic carcinoma, and mucoepidermoid carcinoma. Dr. Agrawal then applied these findings to identify tumor DNA as a biomarkers that improve cancer diagnostics in the saliva and plasma of patients with head and neck squamous cell carcinoma. His research is focused on the application of cancer genetics to design diagnostic approaches to reduce morbidity and mortality from head and neck cancer. In addition to his clinical and research contributions, Dr. Agrawal is an accomplished educator -- teaching medical students, residents, and fellows about the management of patients with head and neck cancer. Prior to joining the University of Chicago, Dr. Agrawal was an associate professor at Johns Hopkins University.

Pediatric Tumors Program

Positions and Employment
University of Parana School of Medicine, Curitiba, Brazil
1980-1984 Assistant Professor of Pediatrics, Department of Pediatrics,
1987-1989 Director, Pediatric Hematology/Oncology, Department of Pediatrics
1987-1989 Adjunct Professor, Department of Pediatrics

Department of Pediatrics, University of Tennessee College of Medicine, Memphis, TN, USA
1989-1995 Assistant Professor,
1995-2002 Associate Professor
2002-present Professor

St. Jude Children's Research Hospital, Memphis, TN, USA
1989-1991 Assistant Member, Department of Hematology/Oncology,
1991-2001 Associate Member, Department of Hematology/Oncology
1997-2013 Director, International Outreach Program
2001-present Member, Department of Hematology/Oncology (Department of Oncology)
2006-2013 Associate Director for Outreach Program of Cancer Center
2006-2013 Director, Leukemia/Lymphoma Division, Department of Oncology

Honors
1993-1994 St. Jude Pediatric Faculty Teaching Award, University of Tennessee, Memphis, TN
2008-2013 Four Stars of Chicago Endowed Chair in International Pediatric Outreach
2009 ACR (American Association for Cancer Research) Team Science Award (SJCRH Acute Lymphoblastic Leukemia Team)
2011 International Network for Cancer Treatment and Research (INCTR): Paul P. Carbone Award-2011 in International Oncology.
2011 Health Care Heroes. 2011 Memphis Business Journal Health Care Provider (Physician) Finalist.
2013 HEMO 2013 Award in Pediatric Hematology Oncology. Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular. Brasila, Brazil.

My main interests include hematological malignancies, adrenocortical tumors and international medicine. I have served as the Director of the St. Jude International Outreach Program (1997 through 2013), Director of the Leukemia/Lymphoma Division (2006 through 2013) and Associate Director for the Outreach Program of the Cancer Center at St. Jude Children’s Research Hospital (2006 through 2013). During the 33 years since I first became associated with St. Jude, my main goals have been to improve the survival of children with malignancies worldwide by providing excellent patient care and engaging in clinical/translational collaborative research. My most important contribution to pediatric oncology has been to lead projects aimed at improving the survival of children with cancer in developing countries. I also collaborate with St. Jude faculty in conducting several clinical trials to increase the survival rates and decrease the toxicity of children with acute lymphoblastic and myeloid leukemias and non-Hodgkin lymphomas. A. Contributions to Science

1. Led the team that discovered the only known founder mutation in the TP53 gene that explains a cluster of pediatric adrenocortical and other tumors in southern Brazil. Using this knowledge participated of the development of a newborn screening for early diagnose and treatment of adrenocortical tumors in children.
2. Creation and implementation of an International Registry for Pediatric Adrenocortical Tumor that is a model to advance knowledge of rare pediatric tumors. Patients from different parts of the world are enrolled in a specific protocol that has the objectives to annotate the clinical, laboratory and outcome of patients with this disease. Moreover, tumor and blood samples are banked for research purposes
3. In collaboration with several investigators from the Department of Oncology, Leukemia/Lymphoma Division, I have participated of the development and implementation of several clinical trials in acute lymphoblastic leukemia designed to improve the survival and decrease the long-term side effects of therapy. This model has been has also adapted to regions of the world with poor resources.
4. In collaboration with investigators from the Departments of Oncology and Pathology, I conduct and participated of the implementation of clinical trials and studies to treat acute myeloid leukemia and myelodysplastic syndrome. The St. Jude AML97 study, of which I was the principal investigator, showed the feasibility, efficacy and toxicity of an anthracycline-free regimen as induction therapy for AML and established the basis for flow-cytometric detection of residual disease in AML

Head and Neck Program

Dr. Susan Muller retired from Emory University October 2013 and is Professor Emeritus and is currently in private practice with Atlanta Oral Pathology. She held joint appointments in the Department of Pathology, Department of Otolaryngology Head and Neck Surgery, and the Winship Cancer Institute beginning in 1995. Dr. Muller enjoys lecturing on Oral Pathology and has lectured throughout the world. She also published on her favorite topics and has more than 200 publications. Dr. Muller is Past President of the American Academy of Oral and Maxillofacial Pathology, immediate Past President of the North American Society of Head and Neck and Past President of the American Board of Oral and Maxillofacial Pathology. Since 2008 Dr. Muller has been Editor-in-Chief of Head and Neck Pathology.

Head and Neck Program

Dr Sondak is Chair of the Department of Cutaneous Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. He is also a Professor in the Departments of Oncologic Sciences and Surgery at the University of South Florida Morsani College of Medicine. He serves as Principal Investigator of the Moffitt Skin SPORE, a major NCI-funded “team science” grant conducting translational research in melanoma and other cutaneous malignancies. His research interests include surgical treatment of melanoma in adults and children; surgical treatment of Merkel cell carcinoma and other rare cutaneous tumors, including dermatofibrosarcoma protuberans; adjuvant and neoadjuvant therapy of melanoma; and evaluation of new therapies for patients with localized or disseminated melanoma. Dr. Sondak has been a leader in studies of surgical treatment of melanoma and other cutaneous malignancies, particularly in the application of sentinel lymph node biopsy and lymph node dissection to the staging and treatment of melanoma and Merkel cell carcinoma, and has been instrumental in training many surgical oncologists in these techniques over the years.

A graduate of Boston University School of Medicine, Dr. Sondak did his surgical training at the University of California Los Angeles. Prior to joining Moffitt in 2004, Dr. Sondak was a Professor of Surgery in the Division of Surgical Oncology at the University of Michigan. Dr. Sondak has received numerous awards, including the Golden Scalpel Award (Outstanding Chief Resident) from the UCLA Division of General Surgery, a Distinguished Alumnus Award from Boston University School of Medicine, the William W. Coon Award for Outstanding Faculty Teaching from the University of Michigan Section of General Surgery, and the Rays of Hope Leadership Award from the Shade Foundation of America, devoted to skin cancer education and prevention for children. He is a member of the National Cancer Institute’s Board of Scientific Counselors for Clinical Sciences and Epidemiology, the group responsible for peer review and oversight of the NCI’s intramural research program. He is also North American Vice President of the Melanoma World Society, and a member of the Lancet Oncology International Advisory Board, as well as an external advisor to several SPORE grants at other US institutions.

Dr Sondak is the author or coauthor of over 390 articles in peer-reviewed publications, over 210 abstracts, and 8 books and 73 book chapters.

Head and Neck Program

Dr. William is a medical oncologist. He was an associate professor and chair of the Head and Neck Medical Oncology at the University of Texas MD Anderson Cancer Center. Today is the head of Medical Oncology at Beneficência Portuguesa de São Paulo and an assistant professor in the Department of Thoracic/Head and Neck Medical Oncology at MD Anderson.

Patients' Forum

- Professor Adriana de Góes Soligo, MD, obstetrician - gynecologist.
- Master’s and Ph.D. degree in Obstetrics and Gynecology from Universidade de Campinas (UNICAMP).
- Professor of Human Reproduction for graduate studies at Instituto Sapientiae since 2010.
- Trainee at IVI Foundation and IVI Clinic in Valencia - Spain.
- Specialist in Assisted Reproduction – Brazilian Federation of Association of Gynecology and Obstetrics (FEBRASGO).
- Member of the American Society for Reproductive Medicine - ASRM.
- Member of the European Society of Human Reproduction and Embriology - ESHRE.
- Author of textbooks - Manual da Gestante and Manual da Infertilidade (Viseu Publishing Co.).

Skin Tumors

- Dermatologist – Brazilian Society of Dermatology.
- Coordinator of the Trichology specialization course at Hospital do Servidor Público Municipal de São Paulo.

Head and neck

Aline Lauda Freitas Chaves, MD, MBA, MSc Medical oncologist Master’s degree in Health Sciences from Universide Federal de São João del-Rei President of the Brazilian Group of Head and Neck Tumors Chair of the Head and Neck Group at the Latin American Cooperative Oncology Group - LACOG Member of the board of directors of the Brazilian Society of Medical Oncology (SBOC) Attending medical oncologista and diretor at DOM Clínica de Oncologia Member of the the following professional organizations: SBOC, SBC, ASCO, ESMO , IAOO

Skin Tumors

- A graduate of Medicine from Universidade de Santo Amaro – UNISA (1997).
- Specialization in Dermatology from UNISA (2000).
- Specialist in Dermatology – Brazilian Society of Dermatology (SBD) and the Brazilian Medical Association (AMB) (2000).
- Master’s in Sciences, Cutaneous Oncology, Fundação Antônio Prudente (2003). 
- Postgraduate studies in Digital Dermoscopy from the Medical University of Graz (Austria – 2007).
- Member of the Brazilian Society of Dermatology (SBD), the Brazilian Society of Surgical Dermatology (SBCD), the Brazilian Melanoma Group (GBM), the American Academy of Dermatology (AAD), the European Academy of Dermatology and Venereology (EADV) and the International Dermoscopy Society (IDS).

Immunotherapy

She holds a BS. degree in Biological Sciences from Universidade de São Paulo. She also holds a Master of Sciences and Ph.D. degrees in Sciences, Biochemistry and Molecular Biology from the Institute of Chemistry of the same university. She specialized in Immunology and Inflammation in two postdoctoral study programs, one at the Ludwig Institute and the other at the Memorial Sloan Kettering Cancer Center.

Today she works as an associate professor at the Institute of Biomedical Sciences where she leads the laboratory of immunomodulation. Her area of research focuses on interactions between tumors and the immune system.

Head and Neck Program

André C. P. L. F. de Carvalho is Full Professor at the University of São Paulo, Brazil. He was Associate Professor at the University of Guelph, Canada. His main research interests are data mining, data science and machine learning. He has published around 400 papers and received several research awards. He is vice-director of the Center for Mathematical Sciences Applied to Industry (CeMEAI), University of São Paulo. He is a member of the International Network for Government Science Advice (INGSA) Latin American and Caribbean Chapter Steering Committee and a member of the Science for Education network.

Skin Tumors

Oncologist surgeon at the Skin Cancer Service at A.C. Camargo Cancer Center Master’s degree in Oncology from Fundação Antônio Prudente Member of the Brazilian Society of Surgical Oncology Member of the Brazilian Melanoma Group (GBM)

Basic to Translational Science

Bachelor's Degree in Biology from Universidade Presbiteriana Mackenzie and Master's Degree from Fundação Antônio Prudente. Currently a PhD student in the Bioinformatics program at Universidade de São Paulo, his research focuses on the human microbiome and other microbial systems.

Communication and Stress Management

Psychologist, professor and clinical supervisor of “Cognitive Behavioral Therapy in Mental Health”, a graduate study course in the Anxiety program at the Institute of Psychiatry – Hospital as Clínicas, School of Medicine at Universidade de São Paulo. He received an award for his studies on Stress Management, Wellbeing and Quality of Life from the Interprofessional Technical Group at the State of São Paulo Department of Health. Mr. Ribeiro is the author of book, book chapters and scientific papers in specialized medical journals.

Skin Tumors

Adjunct Professor of Dermatology, School of Medical Sciences – Universidade Estadual do Rio de Janeiro PhD in Dermatology from Universidade de São Paulo.

Hematology-Oncology

Dr. Chiattone is a graduate of Medicine from Faculdade de Ciências Médicas da Santa Casa de São Paulo (FCMSCSP). Residency program in Internal Medicine and Hematology from Santa Casa de São Paulo, specialization in Hematology and Hemotherapy from the School of Medicine at Universidade de São Paulo (USP). Specialist in Hematology, Hemotherapy and Specialist in Bone Marrow from the Brazilian Association of Hematology and Hemotherapy (Associação Brasileira de Hematologia e Hemoterapia). He holds a master’s degree in Hematology from the School of Medicine at Universidade Federal de São Paulo and a Ph.D. degree in Internal medicine from FCMSCSP. He is full professor at the FCMSCSP Department of Internal Medicine, where he was once the Head of Hematology and Oncology and President of the Library Committee. He is a member of the Committee of International Affairs and member elected of the FCMSCSP Upper Collegiate. He is a professor and advisor of the FCMSCSP Graduate Program in Health Sciences. He was the clinical director of the Blood Center at Irmandade da Santa Casa de Misericórdia de São Paulo, head of Hematology and Hemotherapy services and Chair of the Oncology and Hemotherapy committees. He was the president of the Brazilian Society of Hematology and Hemotherapy (SBHH) from 2004 to 2009 besides being a member of the Board of Directors, the Technical-Scientific committee and the Committee of Diagnostic and Therapeutic Protocols at SBHH. He was the President of the Brazilian Association of Hematology, Hemotherapy and Cell Therapy (organization created following the fusion of the Brazilian Society of Hematology and Hemotherapy and the Brazilian College of Hematology in 2010). Currently he is the director of International Affairs and permanent member of the Board of Directors. Former editor in chief of the Brazilian Journal of Hematology and Hemotherapy, currently he is the associate editor of this journal. He is a permanent member of the Technical Support Group for blood, blood components and blood products at the state of São Paulo Secretariat of Health. He is a member of the technical committee of Oncology Drugs and member of the state of São Paulo Reference Committee on Oncology. He is a member of the Hematology Technical Committee at the Federal Board of Medicine, member of the technical scientific council at the National Institute of Cancer (INCA). He is a member of the Brazilian Association of Hematology and Hemotherapy, member of the Brazilian Association of Bone Marrow Transplantation, member of the American Society of Hematology (ASH), member of the European Hematology Association (EHA) and member of the Brazilian-Italian Society of Hematology (AIBE). He is also the vice-president of AIBE.

Onco Hemato

Graduated in Medicine from Universidade de Brasília, residency in Internal Medicine and Hematology from Universidade Federal de São Paulo (UNIFESP), Ph.D. degree from UNIFESP and post-doctorate degree from Université de Paris VII - Paris – France. Currently dr. Arrais is an assistant professor of Hematology at UNIFESP and attending physician at the Hematology and Transplantation Service of the Oncology Center at Hospital Sírio Libanês.

Patients' Forum

- Coordinator of Psychology services of the Psycho-Oncology center at ACCamargo Center
- Coordinator of the Multidisciplinary Residency program in Health – Psychology at ACCamargo Cancer Center
- Psychoanalyst
- Clinical psychologist
- Specialist in Clinical Psychology – Federal Board of Psychology
- Ph.D. degree in Oncology from Fundação Antonio Prudente – A.C.Camargo Cancer Center
- MS in Oncology from Fundação Antonio Prudente – A.C.Camargo Cancer Center
- Specialization in Psycho-Oncology from Fundação Antonio Prudente – A.C.Camargo Cancer Center
- B.S. in Psychology from Universidade Pauista
- B.A. in Pedagogy from Universidade Paulista http://lattes.cnpq.br/3398025113239331

Immunotherapy

Dr. Nunes is a graduate of Biological Sciences from Pontifícia Universidade Católica de Minas Gerais (1996). She holds a master’s degree in Oncology from Fundação Antônio Prudente (2000) and Ph.D. degree in Sciences (Biochemistry) from Universidade de São Paulo (2004). Postdoctoral program at the MD Anderson Cancer Center (2006-2009). Full researcher at A.C.Camargo Cancer Center since 2011 in Medical Genomics. An expert in biochemistry and molecular biology, particularly cancer, miRNAs, non-coding RNAs, phage-display, extracellular vesicles, liquid biopsy, metagenomics.

Brain Tumors

Douglas Guedes, MD.
Radiation oncologist.
Master’s and Ph.D. degrees in Oncology from A.C.Camargo Cancer Center

Skin Tumors

- Member of the Skin Cancer Center at ACCamargo Cancer Center since 1997
- Master’s degree in Oncology from Fundação Antonio Prudente
- Full member of the Brazilian Society of Plastic Surgery (SBCP)
- Director of the Oncology Chapter at the Brazilian Society of Plastic Surgery (SBCP)

<p style="text-align: center;"><strong>Immunotherapy</strong></p> <p style="text-align: justify;">A graduate from medical school (1985), dr. Murta completed his residency program in Gynecology and Obstetrics from Universidade Federal do Triângulo Mineiro (UFTM) in 1987. In 1988 he became a specialist in Gynecologic Oncology and Mastology, Master’s (1989) and Ph.D. degrees in Gynecology and Obstetrics from the School of Medicine, Universidade de São Paulo – Ribeirão Preto. Doctoral exchange program in Medical Oncology at Pitié-Salpêtrière Hospital, Paris. He started his academic career in 1992 as assistant professor of Gynecology and Obstetrics at UFTM, where he is a full professor today.</p>

Brain Tumors

- Doctor of Medicine from the School of Medicine at Universidade de São Paulo. - Neurosurgeon – DFV Neuro – São Paulo
- Coordinator of Neurology-Neurosurgery – Hospital Alemão Oswaldo Cruz – SP
- Co-coordinator of the Pituitary Gland Disease Center – Hospital Sírio Libanês – SP.

Hematology-Oncology

Dr. Rego graduated from the School of Medicine at Universidade de São Paulo in Ribeirão Preto in 1988. He completed his residency training in Internal Medicine and also Hematology and Hemotherapy at the University Hospital of Universidade de São Paulo in Ribeirão Preto (HCFMRP-USP) (1992). He received a PhD from Universidade de São Paulo in 1998 and was a Postdoctoral Fellow at Memorial Sloan Kettering Cancer Center in New York from 1998 to 2001. He achieved professorship from USP in 2002. He is full professor at the School of Medicine of Universidade de São Paulo in Ribeirão Preto since 2010 and worked as Coordinator of the Hematology and Clinical Oncology Services of HCFMRP-USP from 2010 to 2017, and as Scientific Director of Fundação Hemocentro in Ribeirão Preto from 2010 to 2017. One of the coordinators of the Health Department of the São Paulo State Research Support Foundation (FAPESP), he is a founding member and coordinator of the International Consortium on Acute Leukemias (ICAL), created by the American Society of Hematology with the goal of reducing the gap in treatment outcomes of patients with acute leukemias in developed and developing countries. He is deputy chair of the International Members Committe of the American Society of Hematology (ASH) and Scientific Vice-Chair of the Brazilian Association of Hematology and Hemotherapy (2017-2019). He is the editor of the Brazilian Journal of Medical and Biological Research; deputy editor of the Brazilian Journal of Hematology and Hemotherapy, and associate editor of scientific journals Brood and Annals of Hematology. He is the author of 10 of the 117 publications listed as highlights in the PubMed database.

Hematology-Oncology

Doctor of medicine from Escola Bahiana de Medicina e Saúde Pública
Residency in Hematology at Santa Casa de São Paulo
Former fellow at the Cancer Investigation Center/University Hospital of Salamanca
Master and Ph.D. degrees from the School of Medical Sciences at Santa Casa de São Paulo
Hematologist – University Hospital – Universidade Federal da Bahia
Member of the International Myeloma Society, Member of the International Myeloma Working Group
Member of the Committee of Gammopathies at ABHH

Innovation and Technology Program

PwC Brasil partner and Pharma leader. Ms. Kihara has 25 years’ experience in consulting and auditing with international practice. She integrates PwC global team for health innovation.

She is earning her Ph.D. degree in Health Sciences from the School of University at the University of São Paulo. She has dedicated fifteen years of her career to overcome the industry’s challenges. She leads complex multidisciplinary projects on transformation, governance, IT, operations and risk assurance for private health insurance companies, pharmaceutical companies, public and government agencies.

Patients' Forum

MD, surgical oncologist and director of the Mastology department at ACCamargo Cancer Center. Mastology specialist from the Brazilian Society of Mastology. Dr. Makdissi graduated from the School of Medicine at Universidade Estadual de Londrina – UEL. She holds the title of specialist in General Surgery from the School of Medicine at Universidade de São Paulo and Surgical Oncology from Hospital ACCamargo. Master’s and Ph.D. degrees in Oncology from the School of Medicine at Universidade de São Paulo with focus on molecular genetic studies of breast cancer.

Patients' Forum

Dr. Fabíola is a graduate of Medicine from the School of Medicine of Campos, in Rio de Janeiro, with specialization in Pediatrics, Pediatric ICU and Infectious Disease. She holds a master’s degree in Medical Sciences from the School of Medicine at Universidade de São Paulo – Department of Pediatrics. She is the author of the book De médica a paciente – como o câncer de mama mudou minha vida (From doctor to patient – how breast cancer changed my life).

Basic and Translational Research Program

Dr. Fabio Gandour holds a degree in Medicine, with specialization in Pediatric Surgery. After working in this field for eleven years, dr. Gandour migrated to the IT world. With a Ph.D. degree in Computer Sciences, he joined IBM in 1990, where he worked until February 2018.

In 2006, he foresaw the need to establish a research laboratory in Brazil to promote innovation and to produce positive impact on business. In 2010, BRL – the IBM Brazilian Research Lab opened its doors and Dr. Gandour was the lab chief scientist until he left the company. As chief scientist he developed a communication model supported by brilliant metaphors. This skill became a trade mark and IBM major advantage.

Brain Tumors

Endocrinology and Metabolism Specialist – Brazilian Society of Endocrinology and Metabolism
PhD and Postdoctoral Degree in Endocrinology and Metabolism, School of Medicine, Universidade de São Paulo
Head of the Endocrine Oncology Service, AC Camargo Cancer Center
Staff Physician of the Neuroendocrinology Service, Hospital das Clínicas, School of Medicine, Universidade de São Paulo.

Skin Tumors

Surgical oncologist Full professor of the Melanoma and Skin Department at Associação de Combate ao Câncer in Goiás President of the Brazilian Melanoma Group (GBM) Master’s degree in Medicine from Universidade Federal de Goiás Advisor of the Regional Board of Medicine in Goiás

Skin Tumors

Doctor of Medicine from Universidade Federal de São Paulo (UNIFESP)
Founding Member of the Brazilian Melanoma Group (GBM)
Surgeon Oncologist at Hospital Sírio Libanês, Hospital Alemão Oswaldo Cruz and Beneficência Portuguesa Mirante

Skin Tumors

Assisting professor of Dermatology at the School of Medicine of ABC. Ph.D. in Health Sciences from the University of São Paulo. Master’s in Dermatology from the School of Medicine at Universidade Federal do Estado de São Paulo. Member of the Brazilian Society of Dermatology.

Basic and Translational Science

Dr. Glaucia graduated in Biological Sciences from Universidade de São Paulo. In 2000 she started her Ph.D. degree under Dr. Vilma Martins and Prof. Ricardo Brentani in her search for finding the physiological functions of cell prions at Ludwig Cancer Institute. For many years, dr. Glaucia studied the functions of prions in neurons and non-neuronal cells, identifying ligands that induce neuritogenesis, neuroprotection, memory formation and consolidation. Dr. Glaucia has been the recipiente of many awards, such as the Highly Qualified Personnel Award from PrioNet Canada and the Young Investigator Award from the International Society of Neurochemistry. In 2008, Dr. Glaucia joined the team of researchers at AC Camargo Cancer Center, studying mechanisms that allow for mRNAs to be uniquely translated in the nervous system and in brain tumors. By using the sequencing of RNAs translated mainly in tumors, dr. Glaucia intends to clarify the biological mechanisms related to tumor development and to indicate new treatments

Pediatric tumors

Pediatric dietitian at A.C.Camargo Cancer Center. She graduated from Pontífica Universidade Católica do RS, with specialization in Pediatrics at Hospital de Clínicas de Porto Alegre. She was a resident at the Multiprofessional Residency program in Pediatric Oncology at the Support Group to Adolescents and Children with Cancer (GRAACC) at Universidade Federal de São Paulo (UNIFESP). Master’s degree in Sciences (focus on Oncology) from Fundação Antônio Prudente.

Head and neck

- MD, Ph.D. degree and Post-Doc in Oncology from the School of Medicine, Universidade de São Paulo (FMUSP). - Radiation oncologist, Department of Radiotherapy at Hospital Sírio-Libanês - Radiation oncologist at the Radiotherapy Service, Instituto do Câncer do Estado de São Paulo (ICESP) – FMUSP.

Innovation and Technology Program

Jacson Fressatto is the founder and CEO of LAURA, a platform of Artificial Intelligence. He is a system architect focused on the development of data analytics technologies, machine learning, micro and autonomous services using methodologies of agile management and exponential organizations (ExpO). He became a specialist in corporate security working to large companies such as IBM and Volvo where he was responsible for saving more than USD 18 million in systemic frauds. He established two technology companies and one corporate investigation consulting company. His gold goal is to have positive impact on 1 billion lives”.

Immunotherapy

José Alexandre Barbuto received his medical degree in 1981 from University of São Paulo School of Medicine, completed his specialization in Cellular Immunology at the Max-Planck Institute for Immunology, Tübingen, Germany, and received his Ph.D. in Immunology from the Institute of Biomedical Sciences, University of São Paulo, Brazil. Currently, Dr. Barbuto is Associate Professor in the Department of Immunology at the Institute of Biomedical Sciences and at the Division of Molecular Medicine, Department of Medicine at University of São Paulo School of Medicine.

Hematology-Oncology

Graduate of Medicine from Universidade de São Paulo (1980). Medical residency program from Universidade de Campinas (Unicamp, 1983). Ph.D. degree in Medicine from the University of Muenster, Germany (1986). Full professor of Pathology at the School of Medical Sciences, Unicamp (2005). Professor of the graduate program in Oncology and Hematopathology consultant at Fundação Antonio Prudente, ACCamargo Cancer Center, SP. Owner/partner at Laboratório de Anatomia Patológica Multipat (Pathology Laboratory), Campinas, SP.

Stomatology

Dental surgeon graduated from the College of Dentistry, Universidade de São Paulo. -Master’s and Ph.D degree from the College of Dentistry, Universidade de São Paulo. -Chief of Dentistry and Stomatology at Hospital das Clínicas from the School of Medicine, Universidade de São Paulo - Ribeirão Preto (HCFMRP-USP). -Coordinator of the Multiprofessional Residency Program in Cancer Care at HFMRP-USP.

Skin Tumors

Assistant Professor at the Dermatology Department, Hospital das Clínicas, Universidade de Campinas.
Coordinator of the Melanoma and Dermoscopy Outpatient Service.

Skin Tumors

- MD, dermatologist – Brazilian Society of Dermatology.
- Master’s in Science of Clinical Investigation – University of Barcelona, Spain.
- Fellowship in Dermoscopy and Melanoma at Hospital Clinic, Barcelona, Spain.
- Coordinator of the ambulatory of pigmented lesions at Santa Casa de Porto Alegre.
- Professor of Dermatology at Universidade de Caxias do Sul.

Hematology-Oncology

Luciano J. Costa is a graduate of Medicine from Universidade de São Paulo. He finished his residency program in Internal Medicine and Hematology and received his Ph.D. degree in Pathology from Universidade de São Paulo (USP), fellowship in Hematology and Oncology from University of Colorado and fellowship in Blood and Marrow Transplantation from Mayo Clinic. Associate Professor of Medicine at University of Alabama at Birmingham (UAB), Medical Director of Immune Effector Cellular Therapy Program at UAB and Inspector for the Foundation for Accreditation of Cellular Therapy (FACT). He has more than one hundred scientific papers on hematologic neoplasms and cell therapy published.

Basic and Translational Science and Head and Neck

Ludmilla T. Domingos Chinen: researcher at AC Camargo Cancer Center, coordinator of research on Circulating Tumor Cells. She graduated in Pharmacy-Biochemistry from Universidade Federal de Goiás (UFG0; 1998), she holds a Master’s degree in Tropical Medicine (Immunology) from Instituto de Patologia Tropical e Saúde Pública (IPTSP/UFGo; 2001) and a Ph.D. degree in Sciences (Microbiology and Immunology; 2005) from the Department of Micro-Immunology at Universidade Federal de São Paulo (UNIFESP). Currently she focuses on research of circulating tumor cells (CTCs) and their clinical role.

Hematology-Oncology

Medical Doctor from the School of Medicine at Universidade de São Paulo (USP)
Master's Degree in Hematology from the School of Medicine at USP
Postgraduate Degree in Public Management from Universidade Federal de São Paulo - UNIFESP
Coordinator of the Technical Oncology Service at the city of São Paulo Department of Health

Head and neck

Associate professor, Department of Radiology and Oncology, School of Medicine, Universidade de São Paulo. Coordinator of Graduate Stuies in Oncology at the School of Medicine, Universidade de São Paulo. Chief ot the Innovation in Cancer laboratory – Instituto do Câncer do Estado de São Paulo, Translational Center in Oncology. Dr. Villa has also experience in Microbiology, with emphasis on Virology namely Human Papillomavirus (HPV), cervical cancer, anogenital cancer, epidemiologic studies on HPV in women and men, immunology of HPV infections. Member of the Brazilian Academy of Sciences and recipient of the Brazilian Order of Scientific Merit. She was the recipient of the SCOPUS Brazil award presented by Elsevier.

Oncogenetics

A graduate of Medicine from Universidade de São Paulo, dr. Diz holds a master’s degree in Hematology and Ph.D. degree in Oncology from the same university. She is an assisting professor of Oncology at the Department of Radiology and Oncology of the School of Medicine at Universidade de São Paulo. She is the medical director of multiple specialties and coordinator of the Medical Oncology ambulatory at Instituto do Câncer do Estado de Paulo “Octávio Frias de Oliveira” – ICESP. Assisting physician at Rede D’or - São Luiz. Specialist in Gynecology cancer, famílial cancer and quality of life.

Basic and Translational Science and Head and Neck

Maria Paula Curado is a medical epidemiologist, head of the NEECAN - Center for Cancer Epidemiology and Statistics at the International Research Center (CIPE), A.C. Camargo Cancer Center. Senior Researcher at the International Prevention Research Institute (I-PRI) in Ecully, France, since 2010. She has previous experience in population-based cancer registries at the IARC (WHO). From 1990 to 2006 she was coordinator of the Population-Based Cancer Registry of Goiânia-Goiás. Currently she coordinates case control studies of head and neck cancer in South America, gastric cancer in three Brazilian cities and a cohort study on aging and chronic diseases in three cities of the state of Goiás.

Pediatric Tumors

Graduated in Medicine, Recife-Brazil (1994); specialist in Hematologie Clinique at Hôpital Saint-Louis Paris, 1977-1979; Fellow Researcher at Hammersmith Hospital Pos-Graduated Medical Scool, Hammersmith Hospital, London [1984-1988]; Ph.D in Celular and Molecular Biology- FIOCRUZ, Rio de Janeiro, Brazil. Research Fellow at New York Blood Center, NY [1996-1999]. Experience in Pediatric Hematology, acting on translational research, molecular-epidemiology and epidemiology of childhood leukemia. Presently she is a full-time researcher at Instituto Nacional de Cancer, Rio de Janeiro and is the head of the Brazilian network of childhood leukemia.

Immunotherapy

Biomedical scientist graduated from Universidade Federal do Rio de Janeiro ( UFRJ). Researcher at the National Institute of Cancer (INCA) and specialist at Fundação Oswaldo Cruz, where he is one of the Fiocancer network coordinators. His team studies the interactions between tumors and the immune system, and genetic modification of lymphocytes for developing immune therapies against cancer.

Skin Tumors

MD, dermatologista at the Department of Dermatology, School of Medicine at Universidade Federal do Estado de São Paulo (UNIFESP)

Skin Tumors

MD, master’s and Ph.D. degrees in Dermatology from Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP).

Assistant professor at the Department of Dermatology, Escola Paulista de Medicina, Universidade Federal de São Paulo.

Responsible for Dermatologic Surgery, outpatient clinics of Skin and Nail Tumors at the Department of Dermatology, Escola Paulista de Medicina - UNIFESP.

Founding partner and former president of the Brazilian Melanoma Group (GBM).

President of the Brazilian Society of Dermatologic Surgery (SBCD) - 2017/2018.

Basic and Translational Science

M.D. degree from Universidade Federal do Ceará (1991), Master's degree in Medicine (Nephrology) from Universidade Federal de São Paulo (1997), postgraduate degree in Transplant Immunology from the University of Tours (Diplome des Études Approfondies, France, 1997-1999) , PhD in Medicine (Nephrology) from Universidade Federal de São Paulo (2000), postdoctoral degree from the Imperial College London (2000-2003), and habilitation from Universidade Federal de São Paulo (Medicine) since 2006. He is currently Full Professor of the Immunology Department in the Biomedical Sciences Institute at Universidade de São Paulo (since 2011). Visiting professor at the University of Tours, France. He has experience in Nephrology and Cellular and Applied Immunology, working mainly in the following subjects: renal transplant, experimental models of acute and chronic renal diseases, ischemia and reperfusion injury, regulatory cells and stem cells in renal diseases. More recently, the laboratory has been studying the relationship between the microbiota, cell metabolism and inflammation in allo and autoimmunity models. Level 1A Productivity Grant (2015-2020). Full Member of the State of São Paulo Academy of Sciences.

Oncogenetics

MD, medical oncologist with Master’s and Ph.D. degrees in Medical Oncology. Full professor at the department of Medical Oncology – ACCamargo Cancer Center Director of the Department of Oncogenetics – ACCamargo Cancer Center

Skin Tumors

Master’s degree in Sciences from the School of Medicine, Universidade Federal de São Paulo (UNIFESP) Ph.D. degree in Sciences from the School of Medicine, UNIFESP. Specialization at the Melanoma unit - Institut Clinic de Medicina y Dermatologia - Hospital Clinic de Barcelona Dermatologist at Hospital Israelita Albert Einstein

Hematology-Oncology

Associate professor of Hematology at Universidade Federal do Rio de Janeiro (UFRJ).
Chief of Hematology and Coordinator of the Bone Marrow Transplant program at Hospital Universitário Clementino Fraga Filho, UFRJ.
Professor of Internal Medicine for Graduate students at UFRJ.
Director at the Brazilian Association of Hematology and Hemotherapy.

Patients' Forum

Pharmacist, she graduated from Universidade do Grande ABC MBA in Hospital Management and Health Services - Faculdade Oswaldo Cruz Specialization in Geriatric Oncology – focus on Multidisciplinary Care from Instituto Racine Member of the Brazilian Society of Oncology Pharmacists - SOBRAFO Member of the Group for Elderly Care - CRF Ms. Zanetti Works as a pharmacist in Oncology since 2004 E-mail: renata.zanetti@accamargo.org.br

Skin Tumors

Assistant professor of Dermatology at Universidade Federal do Rio Grande do Sul (UFRGS) Chief of Dermatology at Hospital de Clínicas de Porto Alegre.

Skin Tumors

Dermatologist from Universidade Federal de São Paulo (UNIFESP)
Specialist Degree from the Brazilian Society of Dermatology
Assistant Physician of the Dermatology Outpatient Service at UNIFESP
Member of the Dermoscopy Group at UNIFESP
Coordinator of the Contact Dermatitis Group at UNIFESP
Preceptor of the Dermatology Residency Training Program at UNIFESP
Member of the SBD, SBCD, GBM, IDS and ACDS.

Lung

Physician coordinator of Radiation Therapy services at Beneficência Portuguesa and Beneficência Portuguesa Mirante hospitals. MD from the School of Medicine at Universidade de São Paulo

Onco Hemato

M.D., supervisor of the Bone Marrow Transplant, Oncology and Hematology Unit at Complexo Hospital de Clínicas – Universidade Federal do Paraná (UFPR). Hematologist at Instituto Pasquini de TMO e Hematologia at Hospital Nossa Senhora das Graças in Curitiba - PR. Graduate of Medicine in 2002 from Universidade Federal do Paraná, residency program in Internal Medicine, Hematology and Hematotherapy (2003-2006), specialization in Bone Marrow Transplant in 2007 at Hospital de Clínicas - UFPR, Curitiba - PR. Fellowship in clinical research at EUROCORD - Hôpital Saint Louis, 2008, Paris - France.

Skin Tumors

Associate professor, master’s and Ph.D. degree in Dermatology. Coordinator of Dermoscopy at Escola Paulista de Medicina. Graduate study advisor of Evidence Based Health at Escola Paulista de Medicina.

Pediatric Tumors

Founder of Beaba, a nonprofit organization for demystifying cancer via IT. Ms. Mozzilli graduated in Communication and Marketing from Fundação Armando Álvares Penteado (FAAP), Advertising and Creation from Escola Panamericana de Arte. Graduate studies in IT Project Management from Universidade de São Paulo and in Fundamentals of Integrative Medicine from Instituto Israelita de Ensino e Pesquisa Albert Einstein.

Patients' Forum

Coordinator of Clinical Nutrition at ACCamargo Cancer Center. She is earning her Ph.D. degree in Health Sciences – Oncology. Master’s degree in Oncology. Specialist in Clinical Nutrition and Oncology Nutrition. Chair of the Multidisciplinary Center to Support Surgical Oncology (NUMACO). Coordinator of the Multidisciplinary Residency Program in Oncology Nutrition at ACCamargo Cancer Center.

Patients' Forum

- Graduated from Law School at Centro Universitário Faculdades Metropolitanas Unidas - 2003;
- Graduate studies in Health Law from the School of Medicine at Universidade de São Paulo - 2005-2006;
- Specialist in Hospital and Healthcare Service Management from Fundação Getúlio Vargas - 2007-2008;
- Specialist in Health Law from the School of Public Health at Universidade de São Paulo - 2009-2010;
- Chief legal officer and coordinator of the advocacy team at Instituto Oncoguia;
- Legal counsel at FEHOSP - Federação das Santas Casas e Hospitais Beneficentes do Estado de São Paulo.